Patents Assigned to NEURONASAL, INC.
  • Use of N-acetylcysteine to treat central nervous system disorders
    Patent number: 11963939
    Abstract: The present disclosure describes methods of treating a central nervous system condition associated with oxidative stress using a 5-lipoxigenase activating protein (FLAP) inhibitor, for example, N-acetylcysteine or nordihydroguaiaretic acid. The present disclosure also describes methods of treating a central nervous system condition with N-acetylcysteine and a second therapeutic agent such as prostaglandin E2.
    Type: Grant
    Filed: January 13, 2023
    Date of Patent: April 23, 2024
    Assignees: Neuronasal, Inc., Burke Neurological Institute
    Inventors: Rajiv R. Ratan, Saravanan Karuppagounder, Thomas I. Bradshaw
  • Use of N-acetylcysteine to treat central nervous system disorders
    Patent number: 11660278
    Abstract: The present disclosure describes methods of treating a central nervous system condition associated with oxidative stress using a 5-lipoxigenase activating protein (FLAP) inhibitor, for example, N-acetylcysteine or nordihydroguaiaretic acid. The present disclosure also describes methods of treating a central nervous system condition with N-acetylcysteine and a second therapeutic agent such as prostaglandin E2.
    Type: Grant
    Filed: December 2, 2019
    Date of Patent: May 30, 2023
    Assignees: NEURONASAL, INC., BURKE NEUROLOGICAL INSTITUTE
    Inventors: Rajiv R. Ratan, Saravanan Karuppagounder, Thomas I. Bradshaw